# Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection

> **NCT04897438** · NA · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 40 (actual)

## Conditions studied

- Kidney Transplant Rejection
- Antibody-mediated Rejection
- Kidney Transplant Failure

## Interventions

- **PROCEDURE:** Kidney allograft biopsy depending on donor-derived cell-free DNA levels

## Key facts

- **NCT ID:** NCT04897438
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2023-07-18
- **Final completion:** 2024-09-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04897438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04897438, "Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT04897438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*